Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X7IF
|
||||
Former ID |
DAP000958
|
||||
Drug Name |
L-Carnitine
|
||||
Synonyms |
Bicarnesine; Carnicor; Carniking; Carnilean; Carnitene; Carnitine; Carnitolo; Carnitor; Carnovis; Carrier; Karnitin; Lefcar; Levocarnitina; Levocarnitine; Levocarnitinum; Metina; Levocarnitina [Spanish]; Levocarnitinum [Latin]; Vitamin B T; Vitamin BT; Carniking 50; ST 198; C-1985; Carnitor (TN); DRG-0211; L-Carnitine inner salt; L-carnitine Base; Levocarnitine [USAN:INN]; Carnitine (L-form); Gamma-Trimethyl-beta-hydroxybutyrobetaine; Levocarnitine (JAN/USP/INN); Gamma-Trimethyl-ammonium-beta-hydroxybutirate; L-(-)-Carnitine; L-gamma-trimethyl-beta-hydroxybutyrobetaine; R-(-)-3-hydroxy-4-trimethylaminobutyrate; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; (S)-carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Vitamins
|
||||
Structure |
Download2D MOL |
||||
Formula |
C7H15NO3
|
||||
InChI |
InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1
|
||||
InChIKey |
PHIQHXFUZVPYII-ZCFIWIBFSA-N
|
||||
CAS Number |
CAS 541-15-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
2207, 3612, 841764, 7849237, 8145671, 8157930, 12125266, 15120307, 15171033, 24892238, 29279278, 46475651, 46505864, 48416167, 49747058, 49833446, 49867038, 53788226, 56312758, 56320717, 56320718, 57326565, 77300350, 85165027, 87565251, 91146345, 92308023, 93166761, 103332887, 103944816, 104324626, 115354359, 118307976, 124360711, 124757780, 124811873, 125164584, 126603600, 126608844, 131318133, 131549872, 134224069, 134338232, 134975930, 135692459, 136903840, 137003561, 141954380, 143433319, 143857297
|
||||
ChEBI ID |
ChEBI:16347
|
||||
SuperDrug ATC ID |
A16AA01
|
||||
SuperDrug CAS ID |
cas=000541151
|
||||
Target and Pathway | |||||
Target(s) | Carnitine O-palmitoyltransferase I | Target Info | Activator | [537609] | |
PathWhiz Pathway | Fatty acid Metabolism | ||||
References | |||||
Ref 468010 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4780). | ||||
Ref 536186 | Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.